1.11
price up icon2.78%   0.03
after-market 시간 외 거래: 1.13 0.02 +1.80%
loading
전일 마감가:
$1.08
열려 있는:
$1.07
하루 거래량:
274.78K
Relative Volume:
0.96
시가총액:
$99.57M
수익:
-
순이익/손실:
$-30.15M
주가수익비율:
-1.2198
EPS:
-0.91
순현금흐름:
$-31.63M
1주 성능:
-5.13%
1개월 성능:
+0.91%
6개월 성능:
+27.64%
1년 성능:
-50.22%
1일 변동 폭
Value
$1.04
$1.15
1주일 범위
Value
$1.04
$1.18
52주 변동 폭
Value
$0.49
$2.32

Context Therapeutics Inc Stock (CNTX) Company Profile

Name
명칭
Context Therapeutics Inc
Name
전화
267-225-7416
Name
주소
2001 MARKET STREET, PHILADELPHIA
Name
직원
9
Name
트위터
Name
다음 수익 날짜
2025-03-19
Name
최신 SEC 제출 서류
Name
CNTX's Discussions on Twitter

CNTX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CNTX
Context Therapeutics Inc
1.11 96.88M 0 -30.15M -31.63M -0.91
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.67 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
628.00 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
423.47 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
831.48 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
182.77 39.72B 447.02M -1.18B -868.57M -6.1812

Context Therapeutics Inc Stock (CNTX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-09-18 개시 Guggenheim Buy
2025-04-21 개시 William Blair Outperform
2025-01-08 개시 JMP Securities Mkt Outperform
2024-11-25 개시 D. Boral Capital Buy
2024-05-16 개시 Piper Sandler Overweight

Context Therapeutics Inc 주식(CNTX)의 최신 뉴스

pulisher
06:51 AM

Is Context Therapeutics Inc. a candidate for recovery playAnalyst Upgrade & Low Drawdown Investment Strategies - newser.com

06:51 AM
pulisher
04:23 AM

Is Context Therapeutics Inc. stock a safe buy before earningsWeekly Trend Report & Entry Point Strategy Guides - newser.com

04:23 AM
pulisher
02:57 AM

Is Context Therapeutics Inc. stock poised for growthMarket Sentiment Report & Short-Term High Return Strategies - newser.com

02:57 AM
pulisher
02:48 AM

Why analysts remain bullish on Context Therapeutics Inc. stockWeekly Stock Recap & Low Drawdown Investment Ideas - newser.com

02:48 AM
pulisher
01:07 AM

How to interpret RSI for Context Therapeutics Inc. stockOptions Play & AI Powered Market Entry Strategies - newser.com

01:07 AM
pulisher
Nov 03, 2025

Why hedge funds are buying Context Therapeutics Inc. stockNew Guidance & Verified Momentum Stock Watchlist - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Does Context Therapeutics Inc. stock trade at a discount to peersWeekly Investment Summary & Fast Moving Trade Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Context Therapeutics Inc. stock a defensive play in 2025Quarterly Market Summary & Verified Chart Pattern Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Context Therapeutics Inc. stock positioned well for digital economyInsider Buying & Reliable Breakout Forecasts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using portfolio simulators with Context Therapeutics Inc. includedJuly 2025 Selloffs & Verified Trade Idea Suggestions - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Context Therapeutics Inc. trending in predictive chart modelsWeekly Market Report & Verified Stock Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Context Therapeutics Inc. stock trendline breakdownDividend Hike & Proven Capital Preservation Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Real time scanner hits for Context Therapeutics Inc. explainedForecast Cut & Low Drawdown Momentum Trade Ideas - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Applying chart zones and confluence areas to Context Therapeutics Inc.July 2025 Review & Consistent Profit Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Context Therapeutics Inc. stock a top pick in earnings seasonJuly 2025 Movers & Real-Time Volume Analysis - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

What’s the recovery path for long term holders of Context Therapeutics Inc.Trade Performance Summary & Precise Swing Trade Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

What recovery options are there for Context Therapeutics Inc.Portfolio Gains Report & Comprehensive Market Scan Reports - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Is Context Therapeutics Inc. stock resilient to inflationWeekly Trade Analysis & Fast Exit and Entry Strategy Plans - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Context Therapeutics Grants Stock Options to New Hire - MSN

Oct 31, 2025
pulisher
Oct 31, 2025

Exit strategy if you’re trapped in Context Therapeutics Inc.July 2025 EndofMonth & Comprehensive Market Scan Insights - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

What drives Context Therapeutics Inc stock priceEnergy Sector Updates & Small Budget Trading Ideas - earlytimes.in

Oct 30, 2025
pulisher
Oct 30, 2025

Context Therapeutics (CNTX) Projected to Post Earnings on Wednesday - MarketBeat

Oct 30, 2025

Context Therapeutics Inc (CNTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Context Therapeutics Inc 주식 (CNTX) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Levit Alex C.
Chief Legal Officer, Corp. Sec
Jun 06 '25
Buy
0.58
20,000
11,520
29,000
Minai-Azary Jennifer Lynn
Chief Financial Officer
Jun 06 '25
Buy
0.64
40,010
25,486
80,010
$37.84
price up icon 1.45%
$28.76
price up icon 0.17%
$102.92
price up icon 1.33%
$104.83
price up icon 0.84%
biotechnology ONC
$309.19
price down icon 0.86%
$182.77
price down icon 1.86%
자본화:     |  볼륨(24시간):